Evidence map›Paper›PMID 19053267›Full record

ArticleBiochemistry2008

Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.

A Kathleen McClendon, Amanda C Gentry, Jennifer S Dickey, Marie Brinch, Simon Bendsen, Anni H Andersen, Neil Osheroff

Open access · greenAbstract readComparative Study
In one paragraph

Article in Biochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Structural basis of DNA crossover capture byScience (New York, N.Y.) · 2024
    Article
  8. Article
  9. Chromatinization Modulates Topoisomerase II Processivity.bioRxiv : the preprint server for biology · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Topoisomerases in Immune Cell Development and Function.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  14. Article
  15. SUMO: A Swiss Army Knife for Eukaryotic Topoisomerases.Frontiers in molecular biosciences · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

A Kathleen McClendonDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA.
Amanda C Gentry
Jennifer S Dickey
Marie Brinch
Simon Bendsen
Anni H Andersen
Neil Osheroff
Vanderbilt University · USAarhus University · DK

Funding

BIOCHEMICAL &CHEMICAL TRAINING FOR CANCER RESEARCHT32CA009582 · NCI · VANDERBILT UNIVERSITY · PI David K Cortez · 1987 to 2026
$8.8M
FUNCTION AND BIOLOGY OF EUKARYOTIC DNA TOPOISOMERASESR01GM033944 · NIGMS · VANDERBILT UNIVERSITY · PI OSHEROFF, NEIL · 1985 to 2015
$5.5M
Reproductive Biology: Training for the 21st CenturyT32HD007043 · NICHD · VANDERBILT UNIVERSITY · PI OSTEEN, KEVIN G · 1985 to 2011
$2.3M
NCI NIH HHS 5 T32 CA09582NCI NIH HHS T32 CA009582NICHD NIH HHS 5 T32 HD07043NICHD NIH HHS T32 HD007043NIGMS NIH HHS GM33944NIGMS NIH HHS R01 GM033944
6 · The paper itself

Abstract

Human topoisomerase IIalpha, but not topoisomerase IIbeta, can sense the geometry of DNA during relaxation and removes positive supercoils >10-fold faster than it does negative superhelical twists. In contrast, both isoforms maintain lower levels of DNA cleavage intermediates with positively supercoiled substrates. Since topoisomerase IIalpha and IIbeta differ primarily in their C-terminal domains (CTD), this portion of the protein may play a role in sensing DNA geometry. Therefore, to more fully assess the importance of the topoisomerase IIalpha CTD in the recognition of DNA topology, hTop2alphaDelta1175, a mutant human enzyme that lacks its CTD, was examined. The mutant enzyme relaxed negative and positive supercoils at similar rates but still maintained lower levels of cleavage complexes with positively supercoiled DNA. Furthermore, when the CTD of topoisomerase IIbeta was replaced with that of the alpha isoform, the resulting enzyme preferentially relaxed positively supercoiled substrates. In contrast, a chimeric topoisomerase IIalpha that carried the CTD of the beta isoform lost its ability to recognize the geometry of DNA supercoils during relaxation. These findings demonstrate that human topoisomerase IIalpha recognizes DNA geometry in a bimodal fashion, with the ability to preferentially relax positive DNA supercoils residing in the CTD. Finally, results with a series of human topoisomerase IIalpha mutants suggest that clusters of positively charged amino acid residues in the CTD are required for the enzyme to distinguish supercoil geometry during DNA relaxation and that deletion of even the most C-terminal cluster abrogates this recognition.

Indexed as

Amino Acid SequenceAntigens, NeoplasmBinding SitesDNA-Binding ProteinsDNA CleavageDNA, SuperhelicalDNA Topoisomerases, Type IIHumansMolecular Sequence DataProtein Structure, TertiarySequence DeletionTopoisomerase II InhibitorsAntigens, NeoplasmDNA-Binding ProteinsDNA, SuperhelicalDNA Topoisomerases, Type IITopoisomerase II Inhibitors

Identifiers

PMID19053267
PMCPMC2629653
OpenAlexW2069057836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.